caseSensitivecompositionalcontentcopyrightdatedescriptionexperimentalhierarchyMeaningjurisdictionnamepublisherpurposestatustitleurlversionversionNeeded| Name | Value | Comments | |
|---|---|---|---|
| caseSensitive | true | ||
| compositional | false | ||
| content | complete | ||
| copyright | This material derives from the HL7 Terminology (THO). THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html | ||
| date | 2019-12-01 | ||
| description | HL7-defined code system of concepts used to record event observations regarding what may have caused a product related event. Used in HL7 Version 2.x messaging in the PCR segment. | ||
| experimental | false | ||
| hierarchyMeaning | is-a | ||
| jurisdiction | |||
| name | CausalityObservations | ||
| publisher | Health Level Seven International | ||
| purpose | Underlying Master Code System for V2 table 0252 (Causality Observations) | ||
| status | active | ||
| title | causalityObservations | ||
| url | http://terminology.hl7.org/CodeSystem/v2-0252 | ||
| version | 2.0.0 | ||
| versionNeeded | false | ||
| Code | Display | status | deprecated | status | deprecated | Comments | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AW | Abatement of event after product withdrawn | A | A | A | A | ||||||
| BE | Event recurred after product reintroduced | A | A | A | A | ||||||
| LI | Literature reports association of product with event | A | A | A | A | ||||||
| IN | Event occurred after product introduced | A | A | A | A | ||||||
| EX | Alternative explanations for the event available | A | A | A | A | ||||||
| PL | Effect observed when patient receives placebo | A | A | A | A | ||||||
| TC | Toxic levels of product documented in blood or body fluids | A | A | A | A | ||||||
| DR | Dose response observed | A | A | A | A | ||||||
| SE | Similar events in past for this patient | A | A | A | A | ||||||
| OE | Occurrence of event was confirmed by objective evidence | A | A | A | A | ||||||
| OT | Other | A | A | A | A | ||||||